Reuben Kapur

  • 4678 Citations
  • 37 h-Index
1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Editorial
2012

Targeting Rho associated kinases in leukemia and myeloproliferative neoplasms

Mali, R. S. & Kapur, R., Sep 2012, In : Oncotarget. 3, 9, p. 909-910 2 p.

Research output: Contribution to journalEditorial

Open Access
5 Scopus citations

Targeting SHP2 phosphatase in Myeloproliferative neoplasms

Mali, R. S., Chan, R. & Kapur, R., Jan 1 2012, In : Oncotarget. 3, 10, p. 1049-1051 3 p.

Research output: Contribution to journalEditorial

Open Access
2 Scopus citations
2013

Unique and redundant roles of class IA PI3Kinase regulatory subunits in mast cell development

Mali, R. S. & Kapur, R., Jan 1 2013, In : Cell Cycle. 12, 1, p. 7-8 2 p.

Research output: Contribution to journalEditorial

2016

Targeting LIM kinases in taxane resistant tumors

Prunier, C., Kapur, R. & Lafanechère, L., Aug 1 2016, In : Oncotarget. 7, 32, p. 50816-50817 2 p.

Research output: Contribution to journalEditorial

3 Scopus citations
2018

Kinase inhibitors in clinical practice: An expanding world

Pandey, R. & Kapur, R., Feb 2018, In : Journal of Allergy and Clinical Immunology. 141, 2, p. 522-524 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations
2019

DNA damage on the DOCK in FLT3-ITD-driven acute myeloid leukemia

Pandey, R. & Kapur, R., 2019, In : Haematologica. 104, 12, p. 2330-2332 3 p.

Research output: Contribution to journalEditorial

Open Access